Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Updates on the Perioperative Management of Resectable Non-Small Cell Lung CancerStacey M Frumm, Narjust Florez, Jay M Lee, et al.
Hematology/Oncology Clinics of North America|June 23, 2023
State of Cancer Control in South America: Challenges and Advancement StrategiesIvy Riano, Ana I Velazquez, Lucia Viola, et al.
Cancer Metastasis Reviews|May 15, 2024
Healthcare disparities, screening, and molecular testing in the changing landscape of non-small cell lung cancer in the United States: a reviewRazelle Kurzrock, Aadel A Chaudhuri, David Feller-Kopman, et al.
Cancers|April 13, 2024
Precision Immuno-Oncology in NSCLC through Gender Equity LensesJennifer Marks, Arthi Sridhar, Angela Ai, et al.
Frontiers in Oncology|June 26, 2023
Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populationsShruti Rajesh Patel, Giselle Alexandra Suero-Abreu, Angela Ai, et al.
Hematology/Oncology Clinics of North America|June 17, 2023
An Overview of Cervical Cancer Prevention and Control in Latin America and the Caribbean CountriesIvy Riano, Pamela Contreras-Chavez, Cindy Medina Pabon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.
Cancer|December 24, 2025
Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000-2021Jaclyn LoPiccolo, Angela C Tramontano, Narjust Florez, et al.
The Oncologist|October 7, 2025
Health-related quality of life assessment in trials testing tyrosine kinase inhibitors or immune checkpoints inhibitors in early-stage NSCLCFabio Salomone, Giorgia Novero, Oriana Ciani, et al.
Pageof 7